Gibson, Dunn & Crutcher LLP advised Biosynth Carbosynth, a portfolio company of the KKR Health Care Growth fund, in its acquisition of Pepscan Therapeutics and Pepscan...
You must be a Standard 1 Year member to access this content.
Arthur Cox partnered with Gibson, Dunn & Crutcher LLP in advising Biosynth Carbosynth. Biosynth Carbosynth, a supplier of critical materials to the life science industry, on...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP acted for KKR Next Generation Technology on its growth investment in +Simple, assisted by Scotto Partners. McDermott represented Tikehau. Hogan Lovells...
You must be a Standard 1 Year member to access this content.
Sidley, Homburger and Wolf Theiss advised KKR on the deal. Bär & Karrer acts as legal advisor to Armira and Dr. Urs Spitz in this transaction....
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP and BDGS Associés advised KKR on the deal. Ornikar, a specialist in driver training and road awareness since 2013, announced a €100 million...
You must be a Standard 1 Year member to access this content.
Kromann Reumert and Sidley Austin LLP advised KKR on its purchase. Mazanti-Andersen advises the sellers. Nordic Bioscience A/S, a Danish company and world leader in biomarker...
You must be a Standard 1 Year member to access this content.
